about
CRISPR-Cas Genome Surgery in Ophthalmology.Neuroprotection by (endo)cannabinoids in glaucoma and retinal neurodegenerative diseases.Assessment of Safety and Functional Efficacy of Stem Cell-Based Therapeutic Approaches Using Retinal Degenerative Animal Models.Cell therapy could be a potential way to improve lipoprotein lipase deficiency.Identification of lncRNAs involved in biological regulation in early age-related macular degeneration.Autologous stem cell therapy for inherited and acquired retinal disease.
P2860
description
2017 nî lūn-bûn
@nan
2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Stem Cell Therapies in Retinal Disorders.
@ast
Stem Cell Therapies in Retinal Disorders.
@en
Stem Cell Therapies in Retinal Disorders.
@nl
type
label
Stem Cell Therapies in Retinal Disorders.
@ast
Stem Cell Therapies in Retinal Disorders.
@en
Stem Cell Therapies in Retinal Disorders.
@nl
prefLabel
Stem Cell Therapies in Retinal Disorders.
@ast
Stem Cell Therapies in Retinal Disorders.
@en
Stem Cell Therapies in Retinal Disorders.
@nl
P2093
P2860
P356
P1433
P1476
Stem Cell Therapies in Retinal Disorders
@en
P2093
Aakriti Garg
Stephen H Tsang
P2860
P356
10.3390/CELLS6010004
P50
P577
2017-02-02T00:00:00Z